IP Library Granted Patent US 7,789,910
Granted Patent B2
US 7,789,910 · App. 11/948,298 · Granted Sep 7, 2010

Optical material and method for modifying the refractive index

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,789,910
App. No.
11/948,298
Granted
Sep 7, 2010
Kind
B2
Abstract

A method for modifying the refractive index of an optical, polymeric material. The method comprises irradiating select regions of the optical, polymeric material with a focused, visible or near-IR laser having a pulse energy from 0.05 nJ to 1000 nJ. The irradiation results in the formation of refractive optical structures, characterized by a change in refractive index, exhibit little or no scattering loss, and exhibit no significant differences in the Raman spectrum with respect to the non-irradiated optical, polymeric material. The method can be used to modify the refractive index of an intraocular lens following the surgical implantation of the intraocular lens in a human eye. The invention is also directed to an optical device comprising refractive optical structures, wherein the refractive structures are characterized by a change in refractive index, exhibit little or no scattering loss, and exhibit no significant differences in the Raman spectrum with respect to the non-irradiated optical, polymeric material.

Claims (17)

1. A method for modifying the refractive index of an intraocular lens following the surgical insertion of the intraocular lens in a human eye, the method comprising:

identifying and measuring aberrations caused by the intraocular lens resulting from the surgical procedure, the intraocular lens including an optical, polymeric material;

determining the position and shape of structures to be patterned into the optical, polymeric material of the lens to correct for the aberrations; and

irradiating select regions of the optical, polymeric material with a focused, visible or near-IR laser having a pulse energy from 0.05 nJ to 1000 nJ, wherein the irradiated regions are characterized by a change in refractive index, exhibit little or no scattering loss, and exhibit no significant differences in a Raman spectrum with respect to a Raman spectrum of non-irradiated optical, polymeric material.

2. The method of claim 1 further comprising verifying the vision correction provided by the irradiated regions.

3. The method of claim 1 wherein the focused laser is provided by a compensation scheme of at least two prisms and at least one mirror to compensate for the positive dispersion introduced by a focus objective.

4. The method of claim 1 wherein the optical polymeric material is prepared from one or more (meth)acrylate monomers selected from the group consisting of 2-hydroxymethyl (meth)acrylate, 2-phenylethyl (meth)acrylate, methyl(meth)acrylate and 3-phenylpropyl (meth)acrylate.

5. The method of claim 1 wherein the region of the optical material irradiated by the laser exhibits a positive change in refractive index.

6. The method of claim 5 wherein the positive change in refractive index is from 0.02 to 0.06.

7. The method of claim 1 wherein the pulse energy of the laser is from 0.2 nJ to 100 nJ.

8. The method of claim 1 wherein the pulse energy of the laser is from 0.5 nJ to 10 nJ.

9. The method of claim 7 wherein the visible or near-IR laser generates pulses having a pulse width of 4 fs to 100 fs.

10. The method of claim 7 wherein the optical, polymeric material is a hydrogel.

11. The method of claim 7 wherein the optical polymeric material is prepared from one or more hydrophilic monomeric components, where a homopolymer of said hydrophilic monomeric components would contain at least 20% of water, based on the weight of the homopolymer.

12. The method of claim 1 wherein the focused laser is provided by a compensation scheme of at least two diffractive gratings to compensate for the positive dispersion introduced by a focus objective.

13. The method of claim 1 wherein the focused laser is provided by a compensation scheme of a chirped mirror to compensate for the positive dispersion introduced by a focus objective.

14. The method of claim 1 wherein the focused laser is provided by a compensation scheme of dispersion compensating mirrors to compensate for the positive dispersion introduced by a focus objective.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS Recorded Feb 5, 2019
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 048259/0134 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2015
From: KUNZLER, JAY FRIEDRICH; JANI, DHARMENDRA M.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 035363/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2015
From: KNOX, WAYNE
To: UNIVERSITY OF ROCHESTER
Reel/Frame 035363/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2015
From: DING, LI
To: UNIVERSITY OF ROCHESTER
Reel/Frame 035363/0929 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2014
From: BAUSCH & LOMB INCORPORATED
To: UNIVERSITY OF ROCHESTER
Reel/Frame 033538/0812 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Nov 1, 2010
From: WP PRISM INC.; BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; EYEONICS, INC.
To: CREDIT SUISSE AG, AS ADMINISTRATIVE AGENT
Reel/Frame 025227/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2008
From: KUNZLER, JAY F.; JANI, DHARMENDRA; PINTO, CANDIDO D.; KNOX, WAYNE H.; DING, LI
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 020815/0915 →